−2.4940USD
−97.16 MUSD
770.00 KUSD
34.64 M
About Atreca, Inc.
Sector
Industry
CEO
John A. Orwin
Website
Headquarters
San Carlos
Employees (FY)
90
Founded
2010
ISIN
US04965G1094
FIGI
BBG00P96JT34
Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BCEL is 0.0810 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Atreca, Inc. stocks are traded under the ticker BCEL.
Atreca, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
BCEL earnings for the last quarter are −0.92 USD whereas the estimation was −0.38 USD which accounts for −144.87% surprise. Estimated earnings for the next quarter are −0.35 USD. See more details about Atreca, Inc. earnings.
Atreca, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 216.67 K USD.
Yes, you can track Atreca, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, BCEL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Atreca, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 90.00 employees. See our rating of the largest employees — is Atreca, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Atreca, Inc. EBITDA is −71.49 M USD, and current EBITDA margin is −11.75 K%. See more stats in Atreca, Inc. financial statements.